Article Type
Changed
Thu, 04/04/2019 - 15:05
Display Headline
Why should cancer patients participate in clinical trials?
Article PDF
Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology, Cleveland Clinic; director, Cleveland Clinic Cancer Center; associate editor, Cleveland Clinic Journal of Medicine

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, T40,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 65(9)
Publications
Page Number
497-499
Sections
Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology, Cleveland Clinic; director, Cleveland Clinic Cancer Center; associate editor, Cleveland Clinic Journal of Medicine

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, T40,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Maurie Markman, MD
Chairman, Department of Hematology/Medical Oncology, Cleveland Clinic; director, Cleveland Clinic Cancer Center; associate editor, Cleveland Clinic Journal of Medicine

Address: Maurie Markman, MD, Department of Hematology/Medical Oncology, T40,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 65(9)
Issue
Cleveland Clinic Journal of Medicine - 65(9)
Page Number
497-499
Page Number
497-499
Publications
Publications
Article Type
Display Headline
Why should cancer patients participate in clinical trials?
Display Headline
Why should cancer patients participate in clinical trials?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media